摘要
目的:观察金双歧联合思密达治疗小儿腹泻的临床治疗效果。方法:收治小儿腹泻患儿104例,根据使用药物的不同将其随机分为试验组与对照组,每组52例。两组均给予常规治疗,试验组在此基础上给予金双歧联合思密达治疗,比较两组的临床治疗效果。结果:试验组临床治疗总有效率92.3%高于对照组的73.1%(P<0.05)。结论:在常规治疗基础上应用金双歧联合思密达治疗小儿腹泻,能够有效地提高治疗效果,减少不良反应,是一种安全有效的药物组合。
Objective:To observe the clinical treatment effect of golden bifid combined with smecta in the treatment of infantile diarrhea.Methods:104 patients with infantile diarrhea were selected.They were randomly divided into the experimental group and the control group with 52 cases in each according to different using drugs.Two groups were given conventional treatment,and the experimental group was given golden bifid combined with smecta treatment on this basis.The clinical treatment effects of two groups were compared.Results:The clinical treatment total effective rate(92.3%) of the experimental group was higher than 73.1%of the control group(P<0.05).Conclusion:Applying golden bifid combined with smecta in the treatment of infantile diarrhea on the basis of conventional treatment can effectively improve the treatment effect,and reduce the adverse reactions.It is a safe and effective drug combination.
出处
《中国社区医师》
2015年第19期68-69,共2页
Chinese Community Doctors
关键词
小儿腹泻
金双歧
思密达
疗效观察
Infantile diarrhea
Golden bifid
Smecta
Curative effect observation